HOOKIPA Pharma Inc (HOOK)
0.9123
-0.01
(-0.70%)
USD |
NASDAQ |
May 03, 16:00
0.9123
0.00 (0.00%)
After-Hours: 20:00
HOOKIPA Pharma Cash from Operations (TTM): -57.52M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -57.52M |
September 30, 2023 | -33.16M |
June 30, 2023 | -25.55M |
March 31, 2023 | -24.58M |
December 31, 2022 | -20.00M |
September 30, 2022 | -46.38M |
June 30, 2022 | -47.51M |
March 31, 2022 | -49.89M |
December 31, 2021 | -66.02M |
September 30, 2021 | -64.07M |
June 30, 2021 | -56.80M |
Date | Value |
---|---|
March 31, 2021 | -46.61M |
December 31, 2020 | -39.34M |
September 30, 2020 | -36.83M |
June 30, 2020 | -35.95M |
March 31, 2020 | -36.80M |
December 31, 2019 | -41.73M |
September 30, 2019 | -39.31M |
June 30, 2019 | -37.00M |
March 31, 2019 | -22.08M |
December 31, 2018 | -15.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-66.02M
Minimum
Dec 2021
-20.00M
Maximum
Dec 2022
-42.37M
Average
-39.34M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Gilead Sciences Inc | 8.481B |
Absci Corp | -64.64M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |